Home » Topics » Regulatory

Regulatory
RSS

FDA issues approvable letter for UroXatral

Oct. 15, 2001

Novel combinations claimed by Merck Frosst for depression and anxiety

Oct. 11, 2001

Clinically used pain medication now claimed for IBS

Oct. 11, 2001

Biovail files NDA for FlashDose version of fluoxetine

Oct. 5, 2001

FDA approves Entocort EC for treatment of Crohn's disease

Oct. 5, 2001

Phase II trial to compare two ciprofloxacin formulations for urinary tract infections

Oct. 4, 2001

Atrix submits NDA for Leuprogel Three-Month Depot for prostate cancer

Sep. 28, 2001

sBLA submitted for ARANESP

Sep. 25, 2001

New strength of Zomig-ZMT approved by FDA

Sep. 21, 2001

More flexible and personalized therapy now possible with NeoRecormon

Sep. 20, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...